Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
Author | Al-Shamasi, Al-Anood |
Author | Elkaffash, Rozina |
Author | Mohamed, Meram |
Author | Rayan, Menatallah |
Author | Al-Khater, Dhabya |
Author | Gadeau, Alain-Pierre |
Author | Ahmed, Rashid |
Author | Hasan, Anwarul |
Author | Eldassouki, Hussein |
Author | Yalcin, Huseyin Cagatay |
Author | Abdul-Ghani, Muhammad |
Author | Mraiche, Fatima |
Available date | 2021-11-29T11:05:37Z |
Publication Date | 2021-11-24 |
Publication Name | International Journal of Molecular Sciences |
Identifier | http://dx.doi.org/10.3390/ijms222312677 |
Citation | Al-Shamasi, A.-A.; Elkaffash, R.; Mohamed, M.; Rayan, M.; Al-Khater, D.; Gadeau, A.-P.; Ahmed, R.; Hasan, A.; Eldassouki, H.; Yalcin, H.C.; Abdul-Ghani, M.; Mraiche, F. Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. Int. J. Mol. Sci. 2021, 22, 12677. https://doi.org/10.3390/ijms222312677 |
Identifier | 12677 |
Abstract | Abnormality in glucose homeostasis due to hyperglycemia or insulin resistance is the hallmark of type 2 diabetes mellitus (T2DM). These metabolic abnormalities in T2DM lead to cellular dysfunction and the development of diabetic cardiomyopathy leading to heart failure. New antihyperglycemic agents including glucagon-like peptide-1 receptor agonists and the sodium–glucose cotransporter-2 inhibitors (SGLT2i) have been shown to attenuate endothelial dysfunction at the cellular level. In addition, they improved cardiovascular safety by exhibiting cardioprotective effects. The mechanism by which these drugs exert their cardioprotective effects is unknown, although recent studies have shown that cardiovascular homeostasis occurs through the interplay of the sodium–hydrogen exchangers (NHE), specifically NHE1 and NHE3, with SGLT2i. Another theoretical explanation for the cardioprotective effects of SGLT2i is through natriuresis by the kidney. This theory highlights the possible involvement of renal NHE transporters in the management of heart failure. This review outlines the possible mechanisms responsible for causing diabetic cardiomyopathy and discusses the interaction between NHE and SGLT2i in cardiovascular diseases. |
Sponsor | Qatar University |
Language | en |
Publisher | MDPI |
Subject | sodium–glucose cotransporter inhibitors SGLT1 SGLT2 sodium–hydrogen exchanger NHE1 NHE3 cardiovascular diseases diabetes |
Type | Article |
Issue Number | 23 |
Volume Number | 22 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [709 items ]
-
Mechanical & Industrial Engineering [1339 items ]